Fortrea Holdings (FTRE) Exchange Rate Effect (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Exchange Rate Effect came in at -$800000.0 in Q2 2026, down 118.6% YoY from $4.3 million in Q2 2025, and up 61.9% on a QoQ basis from -$2.1 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Exchange Rate Effect data on file, last reported at -$800000.0 in Q2 2026.
- Quarterly Exchange Rate Effect fell 118.6% year-over-year to -$800000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$5.5 million (down 225.0% YoY) and the FY2025 annual result came in at $4.5 million, up 167.16% from the prior year.
- Exchange Rate Effect rose to -$800000.0 in Q2 2026, from -$2.1 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $4.3 million in Q2 2025 to a low of -$6.3 million in Q4 2024.
- A 5-year average of -$300000.0 and a median of -$800000.0 in 2026 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect plunged 750.0% — and 2025, when it soared 352.94%.
- Tracing FTRE's Exchange Rate Effect over 5 years: stood at $3.7 million in 2022, then declined by 16.22% to $3.1 million in 2023, then plunged by 303.23% to -$6.3 million in 2024, then soared by 58.73% to -$2.6 million in 2025, then jumped by 69.23% to -$800000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$800000.0 (Q2 2026), -$2.1 million (Q1 2026), and -$2.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -287,000.00 |
| 10 | Fortrea Holdings | 1.72 Bn | 1.55 Bn | 139.20 Mn | -800,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -800,000.00 |
| Mar 31, 2026 | -2.10 Mn |
| Dec 31, 2025 | -2.60 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | -6.30 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | -1.70 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | -2.00 Mn |
| Jun 30, 2023 | -200,000.00 |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 3.70 Mn |
| Sep 30, 2022 | -5.50 Mn |